23.400
+1,74%
2026-10-19
Fundamental Analysis
81 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +25.1% | +243.0% | 3 / 3 | -2.1% | +3.86 pp | +3.54 pp | +36.9% | 0.00 | 3.32 | 124 | −2,1% | 20,1 | +25,3% | 3.32 | 37.12 | −91,1% |
| Pts | 4 | 12 | 12 | 0 | 12 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 23.400 (close price on 2026-10-19)EPS (TTM): 7.045
Financial charts
1.Revenue & growth
VND bn124Q2/26
1.Revenue & growth
VND bn124Q2/26
2.Profit & growth
VND bn20,0Q2/26
3.Profit mix (Penman)
VND bn78,6Q2/26
4.Margins & cost structure
%21.1%Q2/26
5.Returns & cash cycle
% · days56.6%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn237Q2/26
8.Funding & debt health
VND bn · times237Q2/26
9.Revenue backlog
VND bn1,02Q2/26
10.Valuation
times · %3,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.247Q2/26
Adjusted EPS growth, latest quarter
25.1%
Average adjusted EPS growth, 3 quarters
81.4%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26